Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Semin Thorac Cardiovasc Surg ; 13(4 Suppl 1): 35-42, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11805947

ABSTRACT

The purpose of this study was to review the results of mitral and tricuspid valve replacement with mitral valve homograft. Twenty-two mitral homografts were used to replace cardiac valves in 20 patients. The mitral valve was replaced in 18 patients, applying the method described by Acar. The tricuspid valve was replaced in 2 patients, attaching one papillary muscle of the graft to the anterior papillary muscle and bringing the other papillary muscle of the graft through a tunnel in the anterior wall of the right ventricle. A concomitant Maze III procedure was performed in 3 patients. Accuracy of the repair was confirmed by intraoperative echocardiography. All patients survived operation and are currently alive. One patient was lost to follow-up. Patients have been followed for up to 3.25 years. All patients have good exercise ability (NYHA class I). Five homografts (25%) have been explanted from the mitral position and one from the tricuspid position. All events occurred during the first year after reoperation. Cardiac valve replacement with mitral valve homograft may be accomplished safely. A technically good operation does not guarantee that the valve will remain competent and an unacceptably high early explant rate may be expected. Use of mitral valve homograft for cardiac valve replacement should be restricted to young patients in whom anticoagulant medication is not indicated or undesirable and for those with resistant infection.


Subject(s)
Heart Valve Diseases/surgery , Mitral Valve/transplantation , Tricuspid Valve/surgery , Adolescent , Adult , Aged , Echocardiography , Female , Humans , Male , Middle Aged , Mitral Valve/diagnostic imaging , Postoperative Complications , Reoperation , Transplantation, Homologous , Tricuspid Valve/diagnostic imaging
2.
J Card Surg ; 15(1): 35-42, 2000.
Article in English | MEDLINE | ID: mdl-11204386

ABSTRACT

BACKGROUND AND AIM: Operations on cardiac valves are being performed more frequently through smaller incisions than traditional midline sternotomy. A variety of alternate incisions have been used, but most of the interest appears to focus on partial sternotomy. The purpose of the study was to review results using a partial lower sternotomy for cardiac valve operations. METHODS: A standard partial lower one-half or two-thirds sternotomy was used for cardiac valve operations in 112 patients. The sternum was divided transversely in the third or second intercostal space and vertically from that point through the xyphoid process. Standard instruments and retraction devices were used. This incision provided adequate exposure for even complex operations to be performed. Small cannulae were placed into the aorta and heart through the primary incision for cardiopulmonary bypass. Vacuum-assisted venous drainage was used. RESULTS: Seventy-four single valve operations were performed. There were 35 double valve and 5 triple valve operations (35.4%) performed. Operative mortality (5.3%) and major complication rates were comparable to full the sternotomy approach. CONCLUSIONS: Partial sternotomy (lower half) provides a smaller incision through which virtually all cardiac valve operations may be performed. Results achieved with this approach are similar to those associated with full sternotomy. The smaller incision is appreciated by patients.


Subject(s)
Heart Valve Diseases/surgery , Heart Valve Prosthesis Implantation/methods , Minimally Invasive Surgical Procedures/methods , Sternum/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Aortic Valve/surgery , Cardiopulmonary Bypass , Coronary Artery Bypass , Female , Heart Valve Diseases/mortality , Humans , Male , Middle Aged , Mitral Valve/surgery , Postoperative Complications/mortality , Surgical Instruments , Tricuspid Valve/surgery
3.
Ann Thorac Surg ; 67(4): 1111-6, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10320259

ABSTRACT

BACKGROUND: Previous midterm experience with the composite spiral saphenous vein graft to bypass the obstructed superior vena cava (SVC) has been favorable. This study looks at the long-term results in patients followed for up to 23 years. METHODS: Sixteen patients aged 17 to 68 years had operation for obstruction of the SVC with SVC syndrome caused by benign disease. Eleven patients had fibrosing mediastinitis with or without caseous necrosis, 4 had thrombosis caused by a catheter or a pacemaker electrode, and 1 had spontaneous thrombosis. All operations were performed using a composite spiral vein graft constructed from the patient's own saphenous vein. Graft diameter ranged from 9.5 to 15.0 mm. Ten grafts were from the left innominate vein, and six grafts were from the right or left internal jugular vein. The grafts were placed to the right atrial appendage in all patients except 1. Follow-up extends from 1 month to 23 years 8 months (mean follow-up, 10.9 years). RESULTS: Fourteen of 16 grafts remain patent for up to 23 years, and all patients but 1 are free from SVC syndrome. One patient required revision of the graft for thrombosis 4 days after operation. Two grafts closed during the first year after operation: one because of recurrence of spontaneous venous thrombosis and the other because of aggressive fibrosing mediastinitis requiring operation for graft revision three times over a 12-year period prior to death. CONCLUSIONS: These data demonstrate that a spiral vein bypass graft for treatment of the obstructed SVC relieves SVC syndrome and has excellent long-term patency.


Subject(s)
Superior Vena Cava Syndrome/surgery , Veins/transplantation , Adolescent , Adult , Aged , Female , Follow-Up Studies , Humans , Male , Mediastinitis/surgery , Methods , Middle Aged , Reoperation , Saphenous Vein/transplantation , Transplantation, Autologous , Treatment Outcome , Vascular Patency
4.
Semin Thorac Cardiovasc Surg ; 11(4 Suppl 1): 191-3, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10660191

ABSTRACT

The purpose of this study was to review the results of mitral valve replacement with mitral valve homograft, applying the method described by Acar, to determine if the method could be reproduced and was safe to use. Fourteen patients had replacement of the mitral valve with homograft. The diseased valve was excised and replaced with a cryopreserved homograft. The papillary muscles of the graft were attached to the papillary muscles of the patient in side-to-side fashion, using multiple stitches of fine monofilament suture. The annulus of the graft was attached to the patient annulus by continuous suture. The repair was supported by annuloplasty ring. All patients had intraoperative echocardiography. Patients were monitored clinically for up to 1.5 years. There were five men and nine women ranging in age from 16 to 70 years (mean = 43 years). Seven had rheumatic, six had degenerative, and one congenital morphology. Concomitant Maze III procedure was performed in three patients. All patients survived and are currently alive and in New York Heart Association functional class I. Thirteen patients have normal sinus rhythm. Only one patient has intermittent atrial fibrillation and is taking digoxin and warfarin. One patient had dehiscence of the recipient papillary muscle that required reoperation for mitral valve replacement with prosthesis. Three patients have moderate mitral valve regurgitation. Mitral valve replacement with homograft may be accomplished safely and reproducibly using the Acar method. Good short-term functional results and maintenance of normal sinus rhythm may be expected. Anticoagulant therapy should not be required.


Subject(s)
Bioprosthesis , Heart Valve Prosthesis , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Mitral Valve/physiopathology , Prosthesis Design
5.
J Thorac Cardiovasc Surg ; 115(2): 371-9; discussion 379-80, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9475532

ABSTRACT

OBJECTIVE: Cryopreserved aortic allograft can be used for aortic valve replacement in congenital, rheumatic, degenerative, and infected native valve conditions, as well as failed prosthetic valves. This study was conducted to determine the long-term results of aortic valve replacement with cryopreserved aortic allografts. METHODS: Aortic valve replacement with cryopreserved aortic allografts was performed in 117 patients from July 1985 until August 1996. All patients requiring aortic valve replacement regardless of valve disease were considered for allograft replacement; the valve was preferentially used in patients under age 55 years and in the setting of bacterial endocarditis. Four operative techniques involving cryopreserved aortic allografts were used: freehand aortic valve replacement with 120-degree rotation, freehand aortic valve replacement with intact noncoronary sinus, aortic root enlargement with intact noncoronary sinus, and total aortic root replacement. Valve function was assessed by echocardiography during the operation in 78 patients (66%) and after the operation in 77 patients (65%). RESULTS: One-hundred eighteen aortic valve replacements with cryopreserved aortic allografts were performed on 117 patients; mean age was 45.6 years (range 15 to 83 years) and mean follow-up was 4.6 years (range up to 11 years). Intraoperative echocardiography disclosed no significant aortic valve incompetence. There were four operative deaths (3%) and seven late deaths; freedom from valve-related mortality at 10 years was 9:3% +/- 4.55%. New York Heart Association functional status at latest follow-up was normal in 98 (94%) patients. On postoperative echocardiography, 90% had no or trivial aortic valve incompetence. Freedom from thromboembolism at 10 years was 100% and from endocarditis, 98% +/- 2.47%. Seven (6%) patients required valve explantation, four for structural deterioration. At 10 years, freedom from reoperation for allograft-related causes was 92% +/- 3.47%. CONCLUSIONS: Aortic valve replacement with cryopreserved aortic allografts can be performed with low perioperative and long-term mortality. Most patients have excellent functional status, and reoperation for valve-related causes is unusual. Aortic valve replacement with cryopreserved aortic allografts demonstrates excellent freedom from thromboembolism, endocarditis, and progressive valve incompetence.


Subject(s)
Aorta/transplantation , Aortic Valve/surgery , Cryopreservation , Heart Valve Prosthesis Implantation , Adolescent , Adult , Aged , Aged, 80 and over , Disease-Free Survival , Female , Graft Survival , Heart Valve Diseases/mortality , Heart Valve Diseases/surgery , Heart Valve Prosthesis Implantation/methods , Humans , Male , Middle Aged , Survival Analysis , Transplantation, Homologous , Treatment Outcome
6.
J Card Surg ; 13(3): 208-17, 1998 May.
Article in English | MEDLINE | ID: mdl-10193992

ABSTRACT

OBJECTIVE: This study evaluates the initial results for safety and efficacy of aortic valve replacement (AVR) using the Medtronic Freestyle Bioprosthesis. METHODS: One hundred three patients underwent AVR with the Medtronic Freestyle Bioprosthesis over a 40-month period. There were 59 male and 44 female patients with a mean age of 74 years (range 36 to 88 years). Valve size ranged from 19 to 27 mm, and all valves were implanted using a freehand subcoronary technique. Anticoagulation with coumadin was only used for atrial fibrillation. Aspirin was given to patients with associated coronary artery disease. Echocardiography to assess transvalvular pressure gradient and effective valve orifice area was performed at discharge, 3 to 6 months, 1 year, and then annually. RESULTS: There were 4 (3.9%) deaths within 30 days of operation and 5 (4.9%) late deaths. Two (1.9%) deaths were valve-related, one from commissural dehiscence and one from bacterial endocarditis. Three (2.9%) deaths, two early and one late, were from other cardiac causes. The remaining deaths were from noncardiac causes. Five (4.9%) patients suffered a thromboembolic event, two had permanent neurological deficits, two had transient neurological events, and one had coronary artery occlusion. Mean transvalvular gradient assessed by echocardiography was low at all time intervals: discharge (12.8 mmHg), 3 to 6 months (11.3 mmHg), 1 year (12.0 mmHg), and 2 years (11.6 mmHg). Mean effective valve orifice area was good at all time intervals: discharge (1.4 cm2), 3 to 6 months (1.5 cm2), 1 year (1.6 cm2), and 2 years (1.6 cm2). Of the 38 patients assessed by echocardiography at 1 year, 33 (87%) had no or trivial valve incompetence and the remainder had mild valve incompetence. CONCLUSIONS: Aortic valve replacement with the Medtronic Freestyle Bioprosthesis has a low incidence of early valve-related mortality and thromboembolism. The bioprosthesis demonstrates good hemodynamic performance even in small diameters and is particularly well suited for older patients and the small aortic root.


Subject(s)
Aortic Valve/surgery , Bioprosthesis , Heart Valve Diseases/surgery , Heart Valve Prosthesis Implantation/methods , Adult , Aged , Aged, 80 and over , Echocardiography , Female , Follow-Up Studies , Heart Valve Diseases/diagnostic imaging , Heart Valve Diseases/physiopathology , Heart Valve Prosthesis Implantation/mortality , Hemodynamics , Humans , Male , Middle Aged , Postoperative Complications/mortality , Prosthesis Design , Safety , Survival Rate , Treatment Outcome
7.
Surg Laparosc Endosc ; 6(3): 205-9, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8743364

ABSTRACT

We conducted a review of laparoscopic appendectomies (LA) and open appendectomies (OA) over a 3-year period, including 720 patients (253 LA, 467 OA) who underwent appendectomy during the study period. Computer records were reviewed with respect to demographics, length of stay, operating room time, operating room cost, hospital cost, and morbidity. All patients were sent surveys to assess their posthospitalization recovery. The LA patients had significant shorter hospital stays (2.06 days vs. 3.44 days, p < .001), lower morbidity rates (5 vs 14%, p < .02), and comparable overall hospital costs ($4,800 vs. $4,950). The LA patients also reported less postoperative pain and were able to return to work sooner. Our results show that LA can significantly decrease morbidity and hospital stay with a comparable hospital cost and result in quicker patient recovery.


Subject(s)
Appendectomy/methods , Laparoscopy/methods , Adult , Appendectomy/economics , Appendicitis/physiopathology , Appendicitis/surgery , Chi-Square Distribution , Costs and Cost Analysis , Female , Humans , Laparoscopy/economics , Length of Stay , Male , Patient Satisfaction , Prognosis
8.
Surg Laparosc Endosc ; 6(2): 140-3, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8680637

ABSTRACT

We report a retrospective review of all patients undergoing both open and laparoscopic Nissen fundoplication from January 1990 through December 1993. Computer data were reviewed to determine the length of hospital stay, hospital costs, and perioperative complications. Questionnaires were sent to patients undergoing Nissen fundoplication. During the study period, 232 patients underwent Nissen fundoplication, and 72 patients underwent laparoscopic Nissen fundoplication. The open group had an average hospital stay of 6.1 days, the laparoscopy group, 1.5 days (p < < 0.001). Total hospital costs for the open group averaged $8,616 versus $4,331 for the group that underwent laparoscopic procedure (p < 0.001). Operating room time averaged 10 min longer for the laparoscopic procedure (p value, nonsignificant). In-hospital morbidity was significantly greater for the open group. In follow-up questionnaires, the laparoscopy group experienced an earlier return to "general health" (p < 0.005) and an earlier return to work.


Subject(s)
Fundoplication/methods , Laparoscopy , Female , Fundoplication/economics , Hospital Charges , Humans , Laparoscopy/economics , Length of Stay , Male , Middle Aged , Morbidity , Postoperative Complications , Retrospective Studies , Treatment Outcome
9.
Rev. méd. Hosp. Gen. Méx ; 56(2): 79-82, abr.-jun. 1993. ilus
Article in Spanish | LILACS | ID: lil-134979

ABSTRACT

Se presentan dos casos a los que se les realizó drenaje transgástrico y, posteriormente, entre los 14 y 20 días del postoperatorio, gastropancreatoscopia por el orificio de gastrostomía. Este procedimiento mostró beneficio ya que fue capaz de proporcionar datos referentes al tamaño y profundidad de la cavidad del absceso y porque posibilitó la limpieza y retiro de restos necróticos de páncreas y la desobstrucción de la boca anastomótica de drenaje transgástrico. Por estas razones y en función de que prácticamente es un método innocuo, se propone su uso para el control postquirúrgico del frenaje interno transgástrico en los abscesos secundarios a pancreatitis


Subject(s)
Humans , Female , Adult , Middle Aged , Pancreatitis/surgery , Cholelithiasis/surgery , Endoscopy, Gastrointestinal , Abscess/surgery , Cholelithiasis/complications , Drainage
10.
Article in Spanish | MEDLINE | ID: mdl-1307400

ABSTRACT

Occurrence of fatal hyperinfection with Strongyloides stercoralis in an immunodepressed patient after kidney transplantation is reported. Physiopathology of the illness is discussed and the seriousness of the hyperinfection syndrome is stressed. Endoscopy with duodenal biopsy is useful for the establishment of diagnosis.


Subject(s)
Immunocompromised Host , Strongyloidiasis/etiology , Adult , Humans , Kidney Transplantation , Male , Strongyloidiasis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...